Pamela Smith, MD - LDN and Multiple Sclerosis (2019 Conference) (LDN, low dose naltrexone)
Pamela Smith, MD discusses the use of LDN in multiple sclerosis (MS). She gives general information about MS, its symptoms and etiology, what exacerbates it, the four types of MS, conventional therapies, personalized medicine (genetic profile) therapies, effects of diet and allergies. The benefits to MS patients from various supplements, therapies, and exercise are presented, as well as the role of various infectious agents’ and mental health in MS. Treatment of MS with LDN is discussed.